Q4 2024 Management View CEO Jeffrey Graves emphasized the impact of a change in accounting estimate for the regenerative medicine program, which resulted in a $9 million reduction in Q4 revenue. He ...
Job reductions will be implemented at the group’s headquarters in Germany and in regional offices. The company has a total workforce of 22,500.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback